HPV Vaccination and Complex Regional Pain Syndrome: Lack of Evidence

EBioMedicine

Volumn 2, Issue 9, 2015, Pages 1014-1015

  Weinbaum, Cindy M ^a   Cano, Maria ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ALLERGIC REACTION; ANAPHYLAXIS; APPENDICITIS; AUTOIMMUNE DISEASE; CEREBROVASCULAR ACCIDENT; COMPLEX REGIONAL PAIN SYNDROME; DISEASE SEVERITY; GUILLAIN BARRE SYNDROME; HUMAN; MOTOR DYSFUNCTION; NOTE; PREVALENCE; PRIORITY JOURNAL; SCORING SYSTEM; SEIZURE; SWEATING; VENOUS THROMBOEMBOLISM; WART VIRUS; PAPILLOMAVIRUS INFECTION; VACCINATION; VIROLOGY;

COMPLEX REGIONAL PAIN SYNDROMES; HUMANS; PAPILLOMAVIRUS INFECTIONS; VACCINATION;

EID: 84953709700     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2015.08.030     Document Type: Note

References (10)

1. EMA to further clarify safety profile of human papillomavirus (HPV) vaccines Press release, (July 13. http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/07/news_detail_002365.jsp&mid=WC0b01ac058004d5c1. Accessed July 29, 2015).
2. Eberth J.M., Kline K.N., Moskowitz D.A., Montealegre J.R., Scheurer M.E. The role of media and the Internet on vaccine adverse event reporting: a case study of human papillomavirus vaccination. J. Adolesc. Health 2014, 54(3):289-295. (Mar).
3. Hariri S., Bennett N.M., Niccolai L.M., Schafer S., Park I.U., Bloch K.C., Unger E.R., Whitney E., Julian P., Scahill M.W., Abdullah N., Levine D., Johnson M.L., Steinau M., Markowitz L.E., HPV-IMPACT Working Group Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States - 2008-2012. Vaccine 2015, 33(13):1608-1613. (Mar 24).
4. Huygen F., Verschueren K., McCabe C., et al. Investigating reports of complex regional pain syndrome: an analysis of HPV-16/18-adjuvanted vaccine post-licensure data. EBioMedicine 2015, (http://www.sciencedirect.com/science/article/pii/S2352396415300608). 10.1016/j.ebiom.2015.07.003.
5. Kinoshita T., Abe R.T., Hineno A., Tsunekawa K., Nakane S., Ikeda S. Peripheral sympathetic nerve dysfunction in adolescent Japanese girls following immunization with the human papillomavirus vaccine. Intern. Med. 2014, 53(19):2185-2200.
6. Markowitz L.E., Dunne E.F., Saraiya M., et al. Centers for disease control and prevention (CDC). Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 2014, 63(No. RR-05):1-30.
7. Richards S., Chalkiadis, Lakshman R., Buttery J.P., Crawford N.W. Complex regional pain syndrome following immunization. Arch. Dis. Child. 2012, 97:913-915.
8. Smith L.M., Strumpf E.C., Kaufman J.S., Lofters A., Schwandt M., Lévesque L.E. The early benefits of human papillomavirus vaccination on cervical dysplasia and anogenital warts. Pediatrics 2015, 135(5):e1131-e1140. (May).
9. VAERS: Vaccine Adverse Event Reporting System (Accessed July 23, 2015). https://VAERS.hhs.gov.
10. Wilson Rose, Paterson Pauline, Chiu Jeremy, Schulz William, Larson Heidi HPV Vaccination in Japan: The Continuing Debate and Global Impacts. A Report of the CSIS Global Health Policy Center 2015, CSIS, Washington DC, (April. http://csis.org/files/publication/150422_Wilson_HPVVaccination2_Web.pdf. Accessed July 29, 2015).